American Journal of Cardiology
Volume 103, Issue 9 , Pages 1255-1260, 1 May 2009

Relation of Plasma Midregional Proatrial Natriuretic Peptide to Target Organ Damage in Adults With Systemic Hypertension

  • Mahyar Khaleghi, MD

      Affiliations

    • Division of Cardiovascular Diseases, Mayo Clinic, Rochester, Minnesota
    • ,
  • Malik A. Al-Omari, MD

      Affiliations

    • Division of Cardiovascular Diseases, Mayo Clinic, Rochester, Minnesota
    • ,
  • Venkateswarlu Kondragunta, PhD

      Affiliations

    • Division of Cardiovascular Diseases, Mayo Clinic, Rochester, Minnesota
    • ,
  • Nils G. Morgenthaler, MD

      Affiliations

    • Research Department, BRAHMS Aktiengesellschaft, Hennigsdorf, Germany
    • ,
  • Joachim Struck, PhD

      Affiliations

    • Research Department, BRAHMS Aktiengesellschaft, Hennigsdorf, Germany
    • ,
  • Andreas Bergmann, PhD

      Affiliations

    • Research Department, BRAHMS Aktiengesellschaft, Hennigsdorf, Germany
    • ,
  • Thomas H. Mosley, MD

      Affiliations

    • Department of Medicine (Geriatrics), University of Mississippi Medical Center, Jackson, Mississippi
    • ,
  • Iftikhar J. Kullo, MD

      Affiliations

    • Division of Cardiovascular Diseases, Mayo Clinic, Rochester, Minnesota
    • Corresponding Author InformationCorresponding author: Tel: 507-266-3964; fax: 507-266-1617

Received 25 November 2008; received in revised form 5 January 2009; accepted 5 January 2009. published online 20 March 2009.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 This work was supported by Grant HL-81331 from the National Institutes of Health, Bethesda, Maryland.

 Dr. Morganthaler, Dr. Struck, and Dr. Bergmann are employed by BRAHMS AG, which developed the assay used for the measurement of MR-proANP in this study.

PII: S0002-9149(09)00104-0

doi:10.1016/j.amjcard.2009.01.012

American Journal of Cardiology
Volume 103, Issue 9 , Pages 1255-1260, 1 May 2009

Article Tools

* Image Usage & Resolution